Top-Rated StocksTop-RatedNYSE:EVH Evolent Health (EVH) Stock Price, News & Analysis $23.66 +1.47 (+6.62%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$22.28▼$23.7850-Day Range$18.40▼$23.7252-Week Range$17.98▼$35.00Volume2.62 million shsAverage Volume1.37 million shsMarket Capitalization$2.75 billionP/E RatioN/ADividend YieldN/APrice Target$42.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Evolent Health alerts: Email Address Evolent Health MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.92 Rating ScoreUpside/Downside77.5% Upside$42.00 Price TargetShort InterestBearish11.95% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.22Based on 2 Articles This WeekInsider TradingN/AProj. Earnings Growth27.78%From $0.90 to $1.15 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.75 out of 5 starsComputer And Technology Sector480th out of 612 stocksManagement Services Industry5th out of 6 stocks 3.5 Analyst's Opinion Consensus RatingEvolent Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.92, and is based on 11 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageEvolent Health has only been the subject of 2 research reports in the past 90 days.Read more about Evolent Health's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted11.95% of the outstanding shares of Evolent Health have been sold short.Short Interest Ratio / Days to CoverEvolent Health has a short interest ratio ("days to cover") of 7.8.Change versus previous monthShort interest in Evolent Health has recently increased by 10.85%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldEvolent Health does not currently pay a dividend.Dividend GrowthEvolent Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EVH. Previous Next 1.8 News and Social Media Coverage News SentimentEvolent Health has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.53 average news sentiment score of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Evolent Health this week, compared to 3 articles on an average week.Search InterestOnly 3 people have searched for EVH on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows4 people have added Evolent Health to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Evolent Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.60% of the stock of Evolent Health is held by insiders.Read more about Evolent Health's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Evolent Health are expected to grow by 27.78% in the coming year, from $0.90 to $1.15 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Evolent Health is -18.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Evolent Health is -18.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEvolent Health has a P/B Ratio of 2.52. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Evolent Health's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad DarwinTop Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.Get Your Free Report About Evolent Health Stock (NYSE:EVH)Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.Read More EVH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EVH Stock News HeadlinesJuly 11, 2024 | prnewswire.comEvolent To Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024June 4, 2024 | prnewswire.comEvolent signs agreement to acquire artificial intelligence utilization management products and team from MachinifyJuly 26, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.May 22, 2024 | seekingalpha.comEvolent Health: Recent Pullback, A Buying Opportunity Or Not? (Rating Downgrade)May 11, 2024 | markets.businessinsider.comOppenheimer Reaffirms Their Buy Rating on Evolent Health (EVH)May 11, 2024 | finance.yahoo.comEvolent Health First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsMay 10, 2024 | finance.yahoo.comEvolent Health Inc (EVH) Surpasses Revenue Estimates Despite Net Loss in Q1 2024May 10, 2024 | finance.yahoo.comEvolent Health, Inc. (NYSE:EVH) Q1 2024 Earnings Call TranscriptJuly 26, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.May 10, 2024 | finanznachrichten.deEvolent Health, Inc.: Evolent Announces First Quarter 2024 ResultsMay 9, 2024 | sfgate.comEvolent Health: Q1 Earnings SnapshotMay 9, 2024 | prnewswire.comEvolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.May 9, 2024 | prnewswire.comEvolent Announces First Quarter 2024 ResultsApril 23, 2024 | msn.comCitigroup Initiates Coverage of Evolent Health (EVH) with Buy RecommendationApril 18, 2024 | investing.comEvolent Health stock maintains price target with Overweight ratingApril 18, 2024 | prnewswire.comEvolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024April 15, 2024 | finance.yahoo.comEvolent Health, Inc. (EVH)April 7, 2024 | finance.yahoo.comRecent 7.4% pullback isn't enough to hurt long-term Evolent Health (NYSE:EVH) shareholders, they're still up 134% over 5 yearsSee More Headlines Receive EVH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today7/26/2024Next Earnings (Confirmed)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorComputer and Technology Industry Management services Sub-IndustryBusiness Services Current SymbolNYSE:EVH CUSIPN/A CIK1628908 Webwww.evolenthealth.com Phone(571) 389-6000Fax571-389-6001Employees4,700Year FoundedN/APrice Target and Rating Average Stock Price Target$42.00 High Stock Price Target$52.00 Low Stock Price Target$34.00 Potential Upside/Downside+77.5%Consensus RatingModerate Buy Rating Score (0-4)2.92 Research Coverage12 Analysts Profitability EPS (Most Recent Fiscal Year)($1.25) Trailing P/E RatioN/A Forward P/E Ratio26.29 P/E GrowthN/ANet Income$-113,040,000.00 Net Margins-5.07% Pretax Margin-6.02% Return on Equity6.90% Return on Assets2.79% Debt Debt-to-Equity Ratio0.57 Current Ratio1.02 Quick Ratio1.02 Sales & Book Value Annual Sales$1.96 billion Price / Sales1.40 Cash Flow$1.99 per share Price / Cash Flow11.91 Book Value$9.38 per share Price / Book2.52Miscellaneous Outstanding Shares116,210,000Free Float114,354,000Market Cap$2.75 billion OptionableOptionable Beta1.54 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Seth Barrie Blackley (Age 45)Co-Founder, CEO & Director Comp: $2MMr. Dan McCarthy (Age 39)CEO of New Century Health & President Comp: $1.4MMr. John Paul Johnson (Age 40)Chief Financial Officer Comp: $1.13MMr. Aammaad Shams (Age 40)Chief Accounting Officer Comp: $341.78kMr. Robert CruzChief Technology OfficerMs. Jessica WhiteChief Information OfficerMr. Seth R. FrankVice President of Investor RelationsMs. Kali BeyahChief People & Brand OfficerDr. John Tam M.D.Chief Strategy OfficerMr. Scott PritchardPresident of Performance SuiteMore ExecutivesKey CompetitorsUL SolutionsNYSE:ULSGlobantNYSE:GLOBMarathon DigitalNASDAQ:MARABilibiliNASDAQ:BILIFive9NASDAQ:FIVNView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 406,837 shares on 7/26/2024Ownership: 1.763%IMA Advisory Services Inc.Sold 1,084 shares on 7/26/2024Ownership: 0.031%HMS Capital Management LLCBought 3,150 shares on 7/24/2024Ownership: 0.009%SeaCrest Wealth Management LLCBought 600 shares on 7/22/2024Ownership: 0.009%Values First Advisors Inc.Bought 9,193 shares on 7/19/2024Ownership: 0.023%View All Insider TransactionsView All Institutional Transactions EVH Stock Analysis - Frequently Asked Questions How have EVH shares performed this year? Evolent Health's stock was trading at $33.03 at the start of the year. Since then, EVH stock has decreased by 28.4% and is now trading at $23.66. View the best growth stocks for 2024 here. How were Evolent Health's earnings last quarter? Evolent Health, Inc. (NYSE:EVH) released its quarterly earnings results on Thursday, May, 9th. The technology company reported $0.16 earnings per share for the quarter, beating analysts' consensus estimates of $0.12 by $0.04. The technology company earned $639.65 million during the quarter, compared to analyst estimates of $601.60 million. Evolent Health had a positive trailing twelve-month return on equity of 6.90% and a negative net margin of 5.07%. What is Seth Blackley's approval rating as Evolent Health's CEO? 12 employees have rated Evolent Health Chief Executive Officer Seth Blackley on Glassdoor.com. Seth Blackley has an approval rating of 100% among the company's employees. This puts Seth Blackley in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. When did Evolent Health IPO? Evolent Health (EVH) raised $150 million in an initial public offering on Friday, June 5th 2015. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers. Who are Evolent Health's major shareholders? Top institutional shareholders of Evolent Health include Bank of New York Mellon Corp (1.76%), Salem Investment Counselors Inc. (0.19%), Harbor Capital Advisors Inc. (0.15%) and Valeo Financial Advisors LLC (0.12%). Insiders that own company stock include Frank J Williams, Seth Blackley, Daniel Joseph Mccarthy, John Paul Johnson, Jonathan Weinberg, Diane Holder, Cheryl Scott, Mary Bridget Duffy and Steve Tutewohl. View institutional ownership trends. How do I buy shares of Evolent Health? Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Evolent Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Evolent Health investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Advanced Micro Devices (AMD), Energy Transfer (ET) and Chipotle Mexican Grill (CMG). This page (NYSE:EVH) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolent Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evolent Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
